AWK vs RNA · P/E 22, rev $4.65B vs rev $10.9M
American Water Works (AWK) versus Atrium Therapeutics, Inc. Common Stock (RNA) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported RNA revenue for 2024-12-31 was $10.9M. Net income was -$322.3M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. RNA currently screens at market cap $217.5M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. RNA currently screens at market cap $217.5M.
Not investment advice. Open the AWK and RNA stock pages for the full models.
Not investment advice.